Wuhan YZY Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2496?
Owner Type	Number of Shares	Ownership Percentage
General Public	5,222,305	2.69%
Institutions	11,282,835	5.82%
VC/PE Firms	13,843,669	7.14%
Employee Share Scheme	16,792,707	8.66%
Individual Insiders	37,988,963	19.6%
Public Companies	51,241,785	26.4%
Private Companies	57,476,936	29.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 20 shareholders own 97.31% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
26.4%	CSPC Pharmaceutical Group Limited	51,241,785	HK$406.9m	0%	no data
10.5%	Qian Yuan	20,399,933	HK$162.0m	0%	no data
8.66%	Wuhan YZY Biopharma Co., Ltd, ESOP	16,792,707	HK$133.3m	0%	no data
7.14%	Tongde Qianyuan (Beijing) Investment Management Co., Ltd.	13,843,669	HK$109.9m	0%	57.85%
5.99%	Nanjing Caizhi No. 2 Enterprise Management Partnership	11,620,412	HK$92.3m	0%	no data
5.26%	Hongfeng Zhou	10,199,921	HK$81.0m	0%	no data
4.27%	Hubei Science Technology Investment Group Co. Ltd	8,286,000	HK$65.8m	0%	no data
4.08%	Long Star Growth Group Limited	7,916,510	HK$62.9m	0%	no data
3.94%	Hainan Boyou Enterprise Management Consulting Center (Limited Partnership)	7,628,713	HK$60.6m	0%	no data
3.71%	Guoxin Sichuang Investment Fund Management (Beijing) Co., Ltd.	7,196,835	HK$57.1m	0%	no data
3.71%	Ningbo Meishan Bonded Port Area Guangrui Hongxiang Equity Investment Partnership (Limited Partnershi	7,196,835	HK$57.1m	0%	no data
3.61%	Wuhan Optics Valley New Technology Industry Investment Co., Ltd.	7,000,000	HK$55.6m	0%	no data
3.54%	Pengfei Zhou	6,869,744	HK$54.5m	0%	no data
1.78%	Nanning Yaoyou Business Consulting Partnership Enterprise (Limited Partnership)	3,447,526	HK$27.4m	0%	no data
1.57%	Gongqingcheng Huiyou Xingyao Phase Ii Equity Investment Partnership (Limited Partnership)	3,038,340	HK$24.1m	0%	no data
1.39%	Wuhan Optics Valley Industrial Investment Co., Ltd.	2,686,000	HK$21.3m	0%	no data
0.72%	Wuhan Optics Valley Growth Venture Capital Management Co., Ltd.	1,400,000	HK$11.1m	0%	no data
0.69%	Chengdu Puhua Kaizhi Biotechnology Co., Ltd.	1,342,600	HK$10.7m	0%	no data
0.19%	Hongwei Guo	370,087	HK$2.9m	0%	no data
0.077%	Chen Linan	149,278	HK$1.2m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 06:39
End of Day Share Price	2025/01/02 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Wuhan YZY Biopharma Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution